Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 190

1.

Cardiovascular disease risk factors in youth with type 1 and type 2 diabetes: implications of a factor analysis of clustering.

Mayer-Davis EJ, Ma B, Lawson A, D'Agostino RB Jr, Liese AD, Bell RA, Dabelea D, Dolan L, Pettitt DJ, Rodriguez BL, Williams D; SEARCH for Diabetes in Youth Study Group.

Metab Syndr Relat Disord. 2009 Apr;7(2):89-95. doi: 10.1089/met.2008.0046.

2.

Prevalence of cardiovascular disease risk factors in U.S. children and adolescents with diabetes: the SEARCH for diabetes in youth study.

Rodriguez BL, Fujimoto WY, Mayer-Davis EJ, Imperatore G, Williams DE, Bell RA, Wadwa RP, Palla SL, Liu LL, Kershnar A, Daniels SR, Linder B.

Diabetes Care. 2006 Aug;29(8):1891-6.

PMID:
16873798
3.

Cardiovascular disease risk in youth with diabetes mellitus.

Wadwa RP.

Rev Endocr Metab Disord. 2006 Sep;7(3):197-204. Review.

PMID:
17160723
4.

Cardiovascular risk factors in Mexican-American children at risk for type 2 diabetes mellitus (T2DM).

Urrutia-Rojas X, Menchaca J, Wadley W, Ahmad N, Lacko A, Bae S, Spellman C, Kudchodkar B, Kudolo G, McConathy W.

J Adolesc Health. 2004 Apr;34(4):290-9.

PMID:
15040998
5.

Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial.

Scott R, Donoghoe M, Watts GF, O'Brien R, Pardy C, Taskinen MR, Davis TM, Colman PG, Manning P, Fulcher G, Keech AC; FIELD Study Investigators.

Cardiovasc Diabetol. 2011 Nov 21;10:102. doi: 10.1186/1475-2840-10-102.

7.

Diabetes and cardiovascular disease. Introduction.

Chait A.

Atheroscler Suppl. 2006 Aug;7(4):1-4. Epub 2006 Jul 5. No abstract available.

PMID:
16822721
8.

Plasma triglycerides, an independent predictor of cardiovascular disease in men: a prospective study based on a population with prevalent metabolic syndrome.

Onat A, Sari I, Yazici M, Can G, Hergenç G, Avci GS.

Int J Cardiol. 2006 Mar 22;108(1):89-95. Epub 2005 Aug 8.

PMID:
16085325
9.

The role of insulin in clustering of serum lipids and blood pressure in children and adolescents. The Cardiovascular Risk in Young Finns Study.

Raitakari OT, Porkka KV, Rönnemaa T, Knip M, Uhari M, Akerblom HK, Viikari JS.

Diabetologia. 1995 Sep;38(9):1042-50.

PMID:
8591817
10.

Cardiovascular disease in insulin dependent diabetes mellitus: similar rates but different risk factors in the US compared with Europe.

Orchard TJ, Stevens LK, Forrest KY, Fuller JH.

Int J Epidemiol. 1998 Dec;27(6):976-83.

PMID:
10024191
11.

Office and ambulatory pulse pressure--association with clinical characteristics and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes (ROADMAP study).

Januszewicz A, Ritz E, Viberti G, Mimran A, Rabelink AJ, Rump LC, Ruilope LM, Katayama S, Ito S, Izzo JL Jr, Haller H.

J Hum Hypertens. 2011 Nov;25(11):679-85. doi: 10.1038/jhh.2010.111. Epub 2010 Dec 9.

PMID:
21150933
12.

Cardiovascular risk factors and metabolic syndrome in alcohol- and nicotine-dependent men and women.

Jarvis CM, Hayman LL, Braun LT, Schwertz DW, Ferrans CE, Piano MR.

J Cardiovasc Nurs. 2007 Nov-Dec;22(6):429-35.

PMID:
18090180
13.

Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity.

Hanley AJ, Festa A, D'Agostino RB Jr, Wagenknecht LE, Savage PJ, Tracy RP, Saad MF, Haffner SM.

Diabetes. 2004 Jul;53(7):1773-81.

14.

Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus.

Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB.

Circulation. 2005 Nov 15;112(20):3066-72. Epub 2005 Nov 7.

15.

Heterogeneous behavior of lipids according to HbA1c levels undermines the plausibility of metabolic syndrome in type 1 diabetes: data from a nationwide multicenter survey.

Giuffrida FM, Guedes AD, Rocco ER, Mory DB, Dualib P, Matos OS, Chaves-Fonseca RM, Cobas RA, Negrato CA, Gomes MB, Dib SA; Brazilian Type 1 Diabetes Study Group (BrazDiab1SG).

Cardiovasc Diabetol. 2012 Dec 27;11:156. doi: 10.1186/1475-2840-11-156.

16.

Potentially modifiable metabolic factors and the risk of cardiovascular disease hospitalizations in urban African Americans with diabetes.

Cook CB, Hentz JG, Tsui C, Ziemer DC, Naylor DB, Miller WJ.

Ethn Dis. 2006 Autumn;16(4):852-8.

PMID:
17061737
17.

Use of confirmatory factor analysis for the identification of new components of the metabolic syndrome: the role of plasminogen activator inhibitor-1 and Haemoglobin A1c.

Boronat M, Saavedra P, Varillas VF, Nóvoa FJ.

Nutr Metab Cardiovasc Dis. 2009 May;19(4):271-6. doi: 10.1016/j.numecd.2008.07.007. Epub 2008 Sep 21.

PMID:
18809301
18.

Cardiovascular risk factors are really linked in the metabolic syndrome: this phenomenon suggests clustering rather than coincidence.

Aizawa Y, Kamimura N, Watanabe H, Aizawa Y, Makiyama Y, Usuda Y, Watanabe T, Kurashina Y.

Int J Cardiol. 2006 May 10;109(2):213-8. Epub 2005 Jul 14.

PMID:
16023231
19.

Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.

Appel SJ, Harrell JS, Davenport ML.

J Am Acad Nurse Pract. 2005 Dec;17(12):535-41.

PMID:
16293162

Supplemental Content

Support Center